Bioverativ execs haul in new fortunes after patiently waiting for Sanofi to bid up its $11.6B exclusive buyout
It took more than 8 months and a series of sweetened offers, but Sanofi $SNY was able to close their $11.6 billion deal to buy …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
